First Astaxanthin Ingredient Granted Non-GMO Status by NSF
AstaReal L10 astaxanthin is now certified under the Non-GMO Project Verified program by NSF International.
Photo © iStockphoto.com/buccaneership
AstaReal Technologies, Inc. (Burlington, NJ) announced today that its AstaReal L10 astaxanthin ingredient is now certified under the Non-GMO Project Verified program by NSF International (Ann Arbor, MI). This marks the first time an astaxanthin ingredient has received non-GMO status from NSF, says AstaReal.
“This is very exciting, not just for us as a supplier, but also for our customers,” says Joe Kuncewitch, national sales manager, AstaReal. “At AstaReal we are constantly working to deliver the best natural astaxanthin product to the consumer. What we’ve demonstrated here with this non-GMO verification is our commitment to that promise.”
AstaReal L10 (10% oil) is created from microalgae Haematococcus pluvialis and produced in Moses Lake, Washington.
In response to the news, Charles DePrince, President and CEO of AstaReal, says in a press release: “As a company, we will continue to dedicate resources to programs like this to further attest our dedication to supply the highest quality, natural astaxanthin to the world.”
In addition to offering non-GMO verification services, NSF International recently launched its new NSF Non-GMO True North certification program.
Read more:
NSF Launches New Non-GMO Certification Program
Astaxanthin Demand Continues to Grow
Natural Astaxanthin Verification Program to Launch in Q1 2016, NAXA Says
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
